| Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning |
36 |
| Long Non-Coding RNAs as Epigenetic Regulators in Cancer |
34 |
| NMDA Receptor Antagonists: Repositioning of Memantine as a Multitargeting Agent for Alzheimer's Therapy |
33 |
| Signaling Pathways in Inflammation and Anti-inflammatory Therapies |
26 |
| Synthesis of Silver Nanoparticles and their Biomedical Applications - A Comprehensive Review |
24 |
| Oxidative Stress and Cancer |
22 |
| Roles of Cyclooxygenase, Prostaglandin E-2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract |
21 |
| Oxidative Stress and Accelerated Aging in Neurodegenerative and Neuropsychiatric Disorder |
18 |
| Protective Mechanisms of Butyrate on Inflammatory Bowel Disease |
18 |
| Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response |
17 |
| pLoc_bal-mPlant: Predict Subcellular Localization of Plant Proteins by General PseAAC and Balancing Training Dataset |
17 |
| Probiotics and Paraprobiotics in Viral Infection: Clinical Application and Effects on the Innate and Acquired Immune Systems |
16 |
| Alginate Nanoparticles for Drug Delivery and Targeting |
16 |
| Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases |
15 |
| Colchicine Pharmacokinetics and Mechanism of Action |
15 |
| Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease |
15 |
| Pollution, Toxicity and Carcinogenicity of Organic Dyes and their Catalytic Bio-Remediation |
15 |
| Role of Melatonin in the Inflammatory Process and its Therapeutic Potential |
15 |
| Human-derived Organ-on-a-Chip for Personalized Drug Development |
14 |
| Profile of Fatty Acids, Tocopherols, Phytosterols and Polyphenols in Mediterranean Oils (Argan Oils, Olive Oils, Milk Thistle Seed Oils and Nigella Seed Oil) and Evaluation of their Antioxidant and Cytoprotective Activities |
14 |
| Antibacterial Metal Oxide Nanoparticles: Challenges in Interpreting the Literature |
13 |
| Expression profile of MicroRNA: An Emerging Hallmark of Cancer |
12 |
| Metal/Metal Oxide Nanoparticles: Toxicity, Applications, and Future Prospects |
12 |
| Diet and Brain Health: Which Role for Polyphenols? |
12 |
| Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus |
11 |
| Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy |
11 |
| Placental Exosomes During Gestation: Liquid Biopsies Carrying Signals for the Regulation of Human Parturition |
11 |
| Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update |
10 |
| Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts |
10 |
| Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications |
10 |
| A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine |
10 |
| Modified LDL Particles Activate Inflammatory Pathways in Monocyte-derived Macrophages: Transcriptome Analysis |
10 |
| The Role of Steroids and NSAIDs in Prevention and Treatment of Postsurgical Cystoid Macular Edema |
10 |
| pNitro-Tyr-PseAAC: Predict Nitrotyrosine Sites in Proteins by Incorporating Five Features into Chou's General PseAAC |
10 |
| Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations |
10 |
| Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review |
10 |
| Integrating Autism Spectrum Disorder Pathophysiology: Mitochondria, Vitamin A, CD Oxytocin, Serotonin and Melatonergic Alterations in the Placenta and Gut |
10 |
| Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach |
9 |
| Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases |
9 |
| Cytoprotective Polyphenols against Chronological Skin Aging and Cutaneous Photodamage |
9 |
| Vitamin D: A Micronutrient Regulating Genes |
9 |
| Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer |
9 |
| Recent Advances on Cytotoxic Sesquiterpene Lactones |
9 |
| The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors |
9 |
| Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes Mellitus |
9 |
| Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic Approach |
9 |
| Therapeutic Efficacy of Molecular Hydrogen: A New Mechanistic Insight |
9 |
| The Landscape of Protein Tyrosine Phosphatase (Shp2) and Cancer |
9 |
| Design of Rhenium Compounds in Targeted Anticancer Therapeutics |
9 |
| M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets |
9 |
